On the Incidence of Acute Rejection (AR) and Allograft Outcome in Kidney Transplant Recipients Using Alemtuzumab Induction.

被引：0
|
作者：
Abate, Mersema [1 ]
Vijay, Dhanya [1 ]
Nourbakhsh, Noureddin [1 ]
Miller, Frederick [1 ]
Suh, Heesuck [1 ]
Darras, Frank [1 ]
Nord, Edward [1 ]
机构：
[1] SUNY Stony Brook, Stony Brook, NY 11794 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2010年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：394 / 394
页数：1
相关论文
共 50 条
  • [31] The Impact of Late Surveillance Biopsy and Importance of "Borderline Rejection" On Allograft Outcome in Kidney Transplant Recipients
    Zachariah, M.
    Dwivedi, A.
    Kandukurti, K.
    Gumber, R.
    Venuto, R.
    Patel, S.
    Sharma, R.
    TRANSPLANTATION, 2014, 98 : 128 - 128
  • [32] A Steroid-Free Regime With Alemtuzumab Induction Significantly Reduced Acute Rejection Rate in Simultaneous Pancreas Kidney Transplant Recipients.
    Bank, J.
    Mallat, M.
    van der Boog, P.
    Braat, A.
    Ringers, J.
    Reinders, M.
    de Fijter, J.
    TRANSPLANTATION, 2014, 98 : 855 - 855
  • [33] Impact of Alemtuzumab Induction on Cardiac Allograft Vasculopathy in Orthotopic Heart Transplant Recipients
    Plazak, M.
    Gao, X.
    Gale, S.
    Reed, B.
    Madathil, R.
    Hammad, S.
    Ravichandran, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 758 - 759
  • [34] Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients
    Gathogo, Esther
    Harber, Mark
    Bhagani, Sanjay
    Levy, Jeremy
    Jones, Rachael
    Hilton, Rachel
    Davies, Graham
    Post, Frank A.
    TRANSPLANTATION, 2016, 100 (04) : 871 - 878
  • [35] Clinical and Pathological Findings in Hepatitis C Positive Renal Transplant Recipients Following Alemtuzumab Induction.
    Jonchhe, S.
    Husson, J.
    Haririan, A.
    Ravichandran, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 330 - 331
  • [36] BK Viremia in Living vs Deceased Donor Renal Transplant Recipients Receiving Alemtuzumab Induction.
    Casale, J. P.
    Pluckrose, D.
    Haririan, A.
    Sparkes, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 936 - 937
  • [37] Poor Outcomes in Elderly Kidney Transplant Recipients Receiving Alemtuzumab Induction
    Hurst, Frank P.
    Altieri, Maria
    Nee, Robert
    Agodoa, Lawrence Y.
    Abbott, Kevin C.
    Jindal, Rahul M.
    AMERICAN JOURNAL OF NEPHROLOGY, 2011, 34 (06) : 534 - 541
  • [38] Antibody-mediated rejection (AMR) in renal allograft recipients treated with alemtuzumab induction
    Pascual, J.
    Pirsch, J.
    Torrealba, J.
    Djamali, A.
    Leverson, G.
    Singh, N.
    Odorico, J.
    Knechtle, S.
    Sollinger, H.
    Samaniego, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 237 - 237
  • [39] Alemtuzumab Induction is Effective and Safe in Elderly Kidney Transplant Recipients.
    Toledo, A.
    Szempruch, K.
    Serrano, P.
    Andreoni, K.
    Kozlowski, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 678 - 678
  • [40] What is the true incidence of acute rejection (AR) in renal transplant recipients receiving calcineurin inhibitors?
    Morris-Stift, G
    Griffiths, D
    Jones, D
    Quiroga, I
    Baboo, R
    Singh, J
    Stockdill, H
    Jones, GV
    Janezic, A
    Baboolal, K
    Jurewicz, WA
    TRANSPLANTATION, 1999, 67 (09) : S547 - S547
12345